Chargement en cours...
Efficiency of Cytokine-Induced Killer Cells in Combination with Chemotherapy for Triple-Negative Breast Cancer
PURPOSE: The treatment of triple-negative breast cancer (TNBC) remains challenging, due to the absence of estrogen, progesterone, and human epidermal growth factor receptors. This study was designed to evaluate the efficiency and safety of cytokine-induced killer (CIK) cell immunotherapy, following...
Enregistré dans:
| Publié dans: | J Breast Cancer |
|---|---|
| Auteurs principaux: | , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Korean Breast Cancer Society
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6015982/ https://ncbi.nlm.nih.gov/pubmed/29963110 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4048/jbc.2018.21.2.150 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|